EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS019-01247 
Organism
Homo sapiens 
Tissue/cell
CD20+ 
Coordinate
chr1:160789160-160791540 
Target genes
Number: 4             
NameEnsembl ID
TF binding sites/motifs
Number: 23             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr1:160789628-160789646GGAAGGAAGGAAGGAAGG+10.83
EWSR1-FLI1MA0149.1chr1:160789645-160789663GGAGGGAGGGAGGGAGGG+6.03
EWSR1-FLI1MA0149.1chr1:160789649-160789667GGAGGGAGGGAGGGAGGG+6.03
EWSR1-FLI1MA0149.1chr1:160789653-160789671GGAGGGAGGGAGGGAGGG+6.03
EWSR1-FLI1MA0149.1chr1:160789640-160789658GGAAGGGAGGGAGGGAGG+7.08
EWSR1-FLI1MA0149.1chr1:160789636-160789654GGAAGGAAGGGAGGGAGG+8.13
EWSR1-FLI1MA0149.1chr1:160789620-160789638GAAAGAAAGGAAGGAAGG+8.57
EWSR1-FLI1MA0149.1chr1:160789632-160789650GGAAGGAAGGAAGGGAGG+9.42
EWSR1-FLI1MA0149.1chr1:160789624-160789642GAAAGGAAGGAAGGAAGG+9.6
Gfi1bMA0483.1chr1:160791048-160791059TGCTGAGATTT-6.32
IRF1MA0050.2chr1:160789589-160789610AAAAAAAAACAGAAAGAGAAA-6.62
IRF1MA0050.2chr1:160789595-160789616AAACAGAAAGAGAAAGAAAGA-7.46
LMX1BMA0703.2chr1:160789983-160789994TTAATTAAAAT-6.62
MEF2AMA0052.3chr1:160789414-160789426ACTAAAAATAGA+6.27
MEF2BMA0660.1chr1:160789414-160789426ACTAAAAATAGA+6.32
MEF2CMA0497.1chr1:160789412-160789427CTACTAAAAATAGAA+6.57
ZNF263MA0528.1chr1:160789625-160789646AAAGGAAGGAAGGAAGGAAGG+6.16
ZNF263MA0528.1chr1:160789629-160789650GAAGGAAGGAAGGAAGGGAGG+6.76
ZNF263MA0528.1chr1:160789642-160789663AAGGGAGGGAGGGAGGGAGGG+7.05
ZNF263MA0528.1chr1:160789633-160789654GAAGGAAGGAAGGGAGGGAGG+7.19
ZNF263MA0528.1chr1:160789637-160789658GAAGGAAGGGAGGGAGGGAGG+7.38
ZNF263MA0528.1chr1:160789646-160789667GAGGGAGGGAGGGAGGGAGGG+7.97
ZNF263MA0528.1chr1:160789650-160789671GAGGGAGGGAGGGAGGGAGGG+7.97
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_18494chr1:160787530-160789552CD4p_CD25-_Il17-_PMAstim_Th
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr1160790939160791134
Number: 2             
IDChromosomeStartEnd
GH01I160817chr1160787531160789552
GH01I160821chr1160790939160791134
Enhancer Sequence
CCAGGTAACA TCACCCATGA CACAGGCTAT GGGGTATCTG GTCCAAATGG AAGTTCTAAA 60
GTCTTGCTGC TCAAAGTGTG GTCTGCTGGC CAGCAGTGTG GGCATCACCC AGGAAACTTG 120
TTAGAAATGC AAAATCTGAC CAGGTGCCGT GGCTCACACC TGTAATCCCA GCACTTCGGG 180
AGGCTGAGGC AGGTAGATCA CTTGAGGCCA GGAGTTCAAG ACCAGCCTGG CCAACAAAGT 240
GAAACCCTGT CTCTACTAAA AATAGAAAAA ATTATCTGGG CATGGTGGTG CACGCCTGTA 300
ATCCCAGCTA CTCGGGAGGC TGAGGCATGA GAATCTATTT AACCTGGGAG GTGGAGGTTG 360
CAGTCAGCCT AGATCACGCC ACTGCACTAC AGTCTGGGCA ACAGGGCAAG ACTCTGTCTC 420
AAAAAAAAAA AAAAAAAACA GAAAGAGAAA GAAAGAGAGA GAAAGAAAGG AAGGAAGGAA 480
GGAAGGGAGG GAGGGAGGGA GGGAGGGAGG GAATCTTGGG CATCACCCCA GAATACTGAT 540
TCCAAACCTG TATTTTAACA AGATCCATAA GTGATTCATA TGCCTACTGA AGTTTGAAAA 600
GGAAGGTAGC ATAGAAACAA AAGCCAAGAT AGACTCCTTA GAGATGGTCA CCAGAGCTAG 660
GAGAGGCAGT CTGTCCCCCA GGGTCTCTAG GGTTCCTTGG GCATTAGCCA TTCACCATTT 720
GAATGTGGAC TACAATGAGG ATGGAGTTAT TGTCTCCATT CTGAGAACAG AGAAACAAAG 780
GCCAGATGGA ACAGTACATC TGTGGTAGAA AAAAATTTAA AACTTAATTA AAATTAAACT 840
TCAGGAGACT GTACAACCTA TTACCTAAGA GCATCGTGGG AAATGGAACT GCTCTGACAG 900
GTTTTAGTGT GGGGAGCTGA GATGCCTGCC TTTACTCCCC CACTCCCATG CCACAGTGTC 960
CTAAAATTTC ACCTTAAACT CTGGAGCTCT GGAGTGCTAA GGAATCCCCA ACCTGTGCTC 1020
ACTCTAACCA AATCCTGCTT TAAAAAATAA ATAAATAAAT AAAAAATAAA ACTATATGTC 1080
ACCCCTCATG GCAGGGATTC CCCATGGAGA TGGAATCAGA GGCAGGACTG GGCAGGGAGC 1140
ATGTGACGAT ATGGGCTCTT CTGATGGAAA AGCATAACCA AGAGACAGGG GGCAAGGAAG 1200
GGAATTAGGC TGGACTATGA AGCTCCCCAT CAGCTCCCTC CTCACTACTG ACAGGACAGA 1260
GCCCTGGTGT CCCCCTGCCT GAACCCTCCT TCCTTGGGCA GAGGGTAAAG AGATGTTGGG 1320
GCCACCACCA CCTCCCTACC TCTTCTCTCC CCCAGAACCC TTCTTGAACC TCCAAGGCCT 1380
GCTTCTTTAA CCTCTCCAAG GTCTCCTCTT CCCTAGATCC ACTGCCACTG CCTTAGTTCA 1440
TGTTGTCACC AATTTGTTGT TTAATTGAAT AGTTTTTTTT TTTTTTTAAT TCAAAAGTCA 1500
GACTGGGCAC GGTGGCTCAC GCCTATAATC CCAGTACTTT GGGAGGCTGA GGCAGGTAGA 1560
TCACCTGAGG TCAGGAATTC AAGACCAGCC TGGCCAACAT GGTGAAACCC CGTCTCTACC 1620
AAAAATATAA AAATTAGCCA GGCATGGTGG CACATGCCTG TAATCCCAGC TACTCTGGAG 1680
GCTGAGGCAG GAGAATCACT TGAACCTGGA AGGCAGAGGT TGCAGTGAGC TGAGACTGCA 1740
CCATTGCACT CCAACCTGGG CAAAAAAAGT GAAACTTTGC TAAAAAAAAA AAAAAAAAAC 1800
CATATATTCA CATGGCATAC AGTTAAAAGT AGTTCTCTTT CCAAATTCCA TCTCCAGGTT 1860
CTAAGTCTCT CCCCCAAGAG ACAACCACTG CTGAGATTTC TACAGACCTG AATCCTTTCA 1920
GAAACTTTTA ATGCATTTGC AGGTTTCATA CATATTTGTG TGGGGAGGGT GTTCCTTTAA 1980
CTTCACATAT GGGAGCAATC TATAACACTT TTTTTCTAAA CCTTGCTTTT TGATCTTAAC 2040
AGTACATCCC AGCAATATTA ATGTTTGTAG ATTAAAACTG ATTCCCATTT ATTCCATTCT 2100
ACACATTTGT TTAACTAATT TACTTTACCA GTCCTTATTA ACAGACATTC TCATTCCTTG 2160
TTACTTCTTT CCTAAAATAT GCTAATAGTT TCTTTGCAGA CTATTTCCTC TCATCACTTT 2220
GCCAAGCTCA ACTCTGACTT CTCTAAAACC CTCAATAGCC CCTAATGGCC TTTGTCTGTT 2280
CAAAAGGCGA TATAACCAAG TGGTCAAGTG TATGGGTTCT GAGGTAGGAT AACCCTGTGC 2340
TCAAACCCTA GCTCTCCTCC TTATGAATCC CTAAGCCTCA 2380